You are here

Zelig Eshhar

(l-r) Dr. Ruth Scherz-Shouval, Prof. Drew Pardoll and Dr. Rony Dahan
30.01.2018

Prof. Pardoll was the keynote speaker at the recent Cancer Immunotherapy symposium sponsored by the...

Prof. Zelig Eshhar
05.04.2016

Prof. Zelig Eshhar

Prof. Zelig Eshhar
09.12.2014

Prof. Zelig Eshhar is the recipient of the Teva Award for Excellence in Memory of Eli Hurvitz

 
Prof. Zelig Eshhar
24.08.2014

Prof. Zelig Eshhar was awarded the Massry Prize by the Meira and Shul G. Massry Foundation
 

Prof. Zelig Eshhar
16.10.2013

Prof. Zelig Eshhar is the recipient of the European Society of Gene and Cell Theraphy (ESGCT) and Human Gene Therapy Outstanding Achievement Award...

 SEM image of the dense microbial ecosystem overlying the 'hilly' gastrointestinal epithelial layer
08.09.2013

Our complicated relationship with the microorganisms in our gut has some surprising consequences for our health

Prof. Zelig Eshhar. New approach to fighting cancer
04.10.2011

Pools of donor immune cells could reduce the cost and expand the applications of an experimental cancer treatment.

Universal Donor Immune Cells
24.07.2011

An approach developed at the Weizmann Institute could make a cancer therapy cheaper and more effective

Prof. Meir Wilchek
12.09.2010
In the late 1980s, Prof. Meir Wilchek  developed an immune cancer therapy that employs "T bodies" – white...

Pages